ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,099.96
      1.02%
      US Tech 100
      17,244.00
      1.57%
      Dow Jones
      38,239.66
      0.40%
      Brent Oil
      88.165
      0.00%
      Bitcoin
      63,010.57
      -1.14%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Medicenna Therapeutics Corporation (MDNA)

      7. Medicenna Therapeutics Corporation (MDNA) News

      MDNA Medicenna Therapeutics Corporation

      0.157
      0.00 (0.00%)
      Apr 25 2024 - Closed
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Medicenna Therapeutics Corporation MDNA NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.00% 0.157 20:00:00
      Open Price Low Price High Price Close Price Prev Close
      0.157 0.157
      more quote information »

      Recent News

      Date Time Source Heading
      4/26/202415:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      4/25/202414:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      4/22/202416:40EDGAR2Form AW - Amendment Withdrawal Request
      4/16/202417:05EDGAR2Form S-8 POS - Securities to be offered to employees in..
      4/16/202417:05EDGAR2Form F-3/A - Registration statement by foreign private..
      4/16/202417:04EDGAR2Form F-10POS - Post-effective amendment to a F-10EF..
      4/09/202414:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      4/04/202414:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      2/14/202407:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      1/24/202416:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      1/09/202410:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      1/05/202409:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      12/22/202314:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      11/09/202308:56GLOBEMedicenna to Present 4 Year Follow-up Phase 2b Bizaxofusp..
      11/08/202310:29EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      11/06/202307:00GLOBEMedicenna Announces Promising Single-Agent Response and..
      11/03/202312:00GLOBEMedicenna Presents Preclinical Data on MDNA113, its Targeted..
      10/27/202307:55GLOBEMedicenna Announces Nasdaq Delisting and Cutback of..
      10/25/202315:51EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      10/25/202307:00GLOBEMedicenna Therapeutics Doses First Patient in Phase 2..
      10/24/202307:18EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      10/24/202307:15GLOBEMedicenna Announces Presentations at the 38th Annual Meeting..
      10/10/202308:57EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      10/10/202307:07GLOBEMedicenna Therapeutics Appoints Humphrey Gardner, M.D., as..
      10/03/202317:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      10/03/202307:00GLOBEMedicenna Presents Preclinical MDNA223 BiSKIT Data at the..
      9/28/202317:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      9/28/202317:00GLOBEMedicenna Announces Results of Annual and Special Meeting of..
      9/28/202310:59EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      9/28/202307:00GLOBEMedicenna to Present at the AACR Special Conference Cancer..
      9/06/202307:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      9/06/202307:00GLOBEMedicenna to Participate at The H.C. Wainwright 25th Annual..
      8/28/202316:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      8/28/202316:49EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      8/28/202307:00GLOBEMedicenna Announces the Appointment of Jeff Caravella as..
      8/14/202316:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      8/14/202307:00GLOBEMedicenna Establishes Boston Presence, Appoints Brent..
      8/09/202317:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      8/08/202309:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      8/08/202307:00GLOBEMedicenna Appoints Dr. Arash Yavari as Chair of Development..
      8/04/202308:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      8/04/202307:00GLOBEMedicenna Therapeutics to Provide Clinical Update from Phase..
      8/01/202312:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      8/01/202309:30GLOBEMedicenna Strengthens IP Portfolio with U.S. Patent Granted..
      7/28/202308:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      7/28/202307:00GLOBEMedicenna Reports First Quarter Fiscal 2024 Financial..
      7/25/202308:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      7/25/202307:00GLOBEMedicenna Presents at National Brain Tumor Society's..
      7/06/202310:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      7/05/202307:00GLOBEMedicenna Extends Period to Exercise Certain Warrants

      Your Recent History

      NASDAQ
      MDNA
      Medicenna Therapeutics
      Delayed Upgrade Clock